IGFBP7 and urinary bladder cancer: Although IGFBP7 expression has previously been proposed as a serum biomarker for bladder cancers [60], whether methylation-dependent mechanisms also regulate IGFBP7 expression in MPM, and to the extent its serum levels could be a useful biomarker in MPM have yet to be addressed.